Local health care provider Austin Regional Clinic is recruiting 250 patients from the Austin area to participate in a late-phase clinical trial for a coronavirus vaccine.
According to an Aug. 7 news release from ARC, this clinical trial will test the safety of a certain vaccine compound. This trial may potentially allow this vaccine to be the first to reach the market, ARC stated.
“This vaccine candidate has the potential to save lives and allow us to return to a way of life that will restore our economy, re-connect our friendships, and continue activities we all enjoy," said Dr. Gretchen Crook, principal investigator for ARC Clinical Research, in the Aug. 7 news release. "ARC Clinical Research was selected as a partner in this study based on our long track record of conducting high quality trials and our speed in enrolling study participants."
ARC Clinical Research is the medical research arm of ARC; it works with pharmaceutical, immunotherapy or medical device partners to conduct clinic studies, according to the organization’s website.
